Glycemic control and perioperative outcomes in patients with diabetes after cardiac surgery Nutritional, Metabolic, Endocrine Diabetes mellitus
Conditions
Interventions
1. Wearing the glucose monitoring sensor:
1.1. Application of the monitoring sensor occurs approximately 1 week before surgery. This is a brief process (15 minutes) during a pre-admission outpatient a
Sponsors
St Vincent's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult patients aged 18 years and over 2. Diabetes 3. Scheduled for elective cardiac surgery
Exclusion criteria
Exclusion criteria: 1. Pregnancy 2. Age <18 years 3. Emergency surgery 4. Patients with diabetes on diet control or a single oral hypoglycemic agent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility 1: The number of eligible patients per week is measured by an audit of the screening and enrolment database at the end of the week Feasibility 2: The number of recruited patients per week is measured by an audit of the screening and enrolment database at the end of the week Feasibility 3: The proportion of recruited patients successfully completing the study is measured at 30 days after surgery from an audit of the study database | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured using the glucose monitoring sensor: 1. Time within target glycaemic range during hospitalisation is measured as the number of hours within the blood glucose range of 3.9-10 mmol/l for the time period starting from the end of surgery until discharge from hospital 2. Time above target glycaemic range during hospitalisation is measured as the number of hours above the glucose level >10 mmol/l for the time period starting from the end of surgery until discharge from hospital 3. Time below target glycaemic range during hospitalisation is measured as the number of hours below the glucose level <3.9 mmol/l for the time period starting from the end of surgery until discharge from hospital 4. Time within target glycaemic range during hospitalisation is measured as the number of hours within the blood glucose range of 3.9-10 mmol/l for the time period starting from discharge from hospital until 7 to 14 days after 5. Time below target glycaemic range during hospitalisation is measured as the number of hours within the blood glucose range below 3.9 mmol/l for the time period starting from discharge from hospital until 7 to 14 days after 6. Time above target glycaemic range during hospitalisation is measured as the number of hours within the blood glucose range greater than 10 mmol/l for the time period starting from discharge from hospital until 7 to 14 days after 7. The proportion of patients with one or more major complications including: acute myocardial infarction, stroke, sepsis, reoperation and mortality is measured using the medical records and a follow-up phone call at 30 days after surgery 8. The proportion of patients with one or more infective complications (%) including: sternal wound infection, other surgical wound infection, pneumonia or urinary tract infection is measured using medical records and patient follow-up phone call at 30 days after surgery 9. Hospital length of stay (days) is measured by accessing patient medical records at the end of the ho | — |
Countries
Australia
Contacts
Public ContactTuong;Tuong Phan;Phan
;
Outcome results
None listed